FATE – fate therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at the AACR Annu
Fate Therapeutics Details Off-the-Shelf CAR T Progress in Lupus and Solid Tumors at Needham Conference [Yahoo! Finance]
Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Scalable Biotech Manufacturing Unlocks a $14B Market
Form ARS FATE THERAPEUTICS INC For: Dec 31
Form DEFA14A FATE THERAPEUTICS INC
Form DEF 14A FATE THERAPEUTICS INC For: Jun 12
Form 4/A FATE THERAPEUTICS INC For: Apr 20 Filed by: Redmile Group, LLC
Form 4 FATE THERAPEUTICS INC For: Apr 20 Filed by: Redmile Group, LLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.